13 On the other hand, Haldar et al 14 described that treatment 
myeloid leukemia cell lines, which was accompanied by down-regulation of Bcl-2, Bcl-X L and Bax. Furthermore, we also demonstrated that overexpression of either Bcl-X L or BclIntroduction 2 blocked OA-induced apoptosis in K562 cells.
Phosphorylation and dephosphorylation of cellular proteins are implicated in many biologically important processes such Materials and methods as cell growth and differentiation. Protein phosphorylation has been recently implicated in pathways that lead to apoptosis.
Cell culture
Apoptosis is induced in U937 myeloid leukemia cells by cellpermeable analogues of ceramide. 1 One of the candidate K562, KU812 and HL-60 myeloid cell lines were maintained ceramide-regulated targets is ceramide-activated protein phosin RPMI 1640 medium (Seromed; Biochrom KG, Berlin, phatase (CAPP), which belongs to the phosphatase class 2A Germany) supplemented with 10% heat-inactivated fetal calf (PP2A) family of serine/threonine protein phosphatases. 2 Furserum (Flow Laboratories, Irvine, UK), non-essential aminothermore, ceramide-induced apoptosis is inhibited by okadaic acids, 2 mM glutamine, 100 U/ml penicillin and 100 g/ml acid (OA), an inhibitor of serine/threonine protein phosphastreptomycine. Viability and total cell counts were determined tases, being more potent on the PP2A type phosphatases. [2] [3] [4] at various times by trypan blue exclusion and counting of at Okadaic acid also inhibits glucocorticoid-induced apoptosis least 200 cells from each individual culture. Cells (5-9 × 10 5 in murine T cell hybridomas 5 and apoptosis induced in B cell cells/ml) were cultured in the presence of 15 nM okadaic acid lymphoma and T cell leukemia lines by either heat treatment (Boehringer Mannheim, Mannheim, Germany) for various or ionizing radiation. 6 Apoptosis of lymphoid tumor cells is times. In some experiments, cells were treated with 5 nM accompanied by dephosphorylation of a limited number of calyculin A (Boehringer Mannheim). specific proteins and OA is able to prevent apoptosis and protein dephosphorylation in these cells. 6 On the contrary, this inhibitor of protein phosphatases has been described to Apoptotic cell death analysis induce apoptosis in different mammalian cells, 7 mouse fibroblasts, 8 human breast tumor cells, 9 HeLa cells, 10 and K562, Morphological characteristics of apoptosis were examined HL-60 and U937 myeloid leukemic cells. 11, 12 Thus OA has under a light microscope following 48 h of treatment with OA. opposite effects on apoptosis depending on the cell system For the DNA fragmentation analysis, cells were treated as studied.
described previously. 17 Briefly, cell pellets were resuspended in lysis buffer containing 0.5% SDS and centrifuged. Supernatants were incubated with 0.5 mg/ml proteinase K, 
mRNA expression analysis
Western blotting analysis
The expression of Bcl-X L , Bcl-2 and Bax proteins was determTotal RNA was prepared by the guanidinium thiocyanate ined by Western blotting as previously described. 18 Blots were method. 19 To assess mRNA expression, a reverse transcriptase incubated with rabbit anti-Bcl-X antiserum (Transduction Lab-PCR (RT-PCR) method was employed as described preoratories, Lexington, KY, USA), rabbit anti-Bcl-2 or rabbit antiviously. 18 Briefly, for the RT reaction, RNA (10 g) was primed Bax (both from Santa Cruz Biotechnology, Santa Cruz, CA, with random hexamer and reverse transcribed with USA) and then incubated with goat anti-rabbit IgG conjugated Superscript MMLV reverse transcriptase (Life Technologies, to alkaline phosphatase (Tropix, Bedford, MA, USA). Bound Gaithersburg, MD, USA) in a 20 l volume. The generated antibody was detected by chemiluminescence (Tropix). cDNA was amplified by using primers for human Bcl-2, Bcl-X, Bax and BCR/ABL. 18 The expected PCR products: 367 bp (Bcl-2), 340 bp (Bcl-X L ), 151 bp (Bcl-X s ), 196 bp (Bax) and Results 197 bp (BCR-ABL) were size fractionated onto a 2% agarose gel and stained with ethidium bromide.
The expression of mRNA following treatment with OA was The phosphatase inhibitor OA has been found to induce cell cycle arrest and apoptotic cell death of the human myeloid analyzed by Northern blot using standard procedures. 20 Total RNA (20 g/lane) was electrophoresed onto a 1% agarose forleukemia cell lines HL-60 and K562. 11, 12, 21 Here, we have analyzed the mRNA and protein expression of three regulators maldehyde gels and transferred to a nitrocellulose filter. The PCR fragments described above and probes for c-fos, vimentin of apoptosis (Bcl-2, Bcl-X L and Bax) in HL-60, K562 and KU812 after treatment with OA. Figure 1a shows that KU812 (both from ATCC, Rockville, MD, USA) and ⑀-globin (kindly provided by Dr Tariq Enver, University of Seattle) were radioand K562 cells express Bcl-X L , but neither Bcl-2 nor Bcl-X S , an alternatively spliced form of Bcl-X, which should be labeled by random priming with ␣ 32 P-CTP (3000 Ci/mmol) (Amersham Life Science, Arlington Heights, IL, USA) and used detected as a band just below that of Bcl-X L . RT-PCR analysis also detected that HL-60 cells expressed both Bcl-2 and Bclto hybridize the filters.
X L and that all three myeloid cell lines expressed Bax, a functional regulator of Bcl-2.
22,23 K562 and KU812 cells expressed the BCR-ABL gene, the molecular hallmark of CML (Figure 1a) .
When K562 and KU812 cells were incubated for 2 days with a concentration of OA (15 nM) that has been described to inhibit the activity of protein phosphatase type 2A in K562 cells, 24 Bcl-X L mRNA levels were downregulated (Figure 1b ). Northern analysis showed that both Bcl-2 and Bcl-X L were downregulated with OA in HL-60 cells, although the expression of Bcl-X L was difficult to detect with this technique (Figure 1b) . We also showed that the pattern of expression of Bax was similar to that observed for the other two genes, ie Bax mRNA levels were downregulated upon exposure of the three cell lines to OA for 1-2 days. To further verify these findings, the levels of Bcl-X L , Bcl-2, and Bax protein were assessed by Western blot analysis (Figure 2 ). In agreement with the mRNA results, these three members of the Bcl-2 family were downregulated within 2 to 4 days of OA treatment. To rule out the possibility that the Bcl-2, Bcl-X L and Bax downregulation was due to a general loss of gene expression induced by OA, we analyzed the expression of c-fos, vimentin and ⑀-globin in K562 cells treated with OA. As shown in Figure 1c , no elevation of ⑀-globin mRNA and an increase in the expression of c-fos and vimentin was detected.
We next determined whether the loss of expression observed of Bcl-2 and Bcl-X L was accompanied by an increase in cell death. Figure 3a shows the percentage of viable K562, HL-60 and KU812 cells at various times following treatment with OA. The percentage of viable HL-60 cells fell dramatically by day 2 of OA treatment (21% viable) and dropped to less than 2% by day 4 (Figure 3a) . Loss of viability of K562 somal fragments (Figure 3b ). Since calyculin A is another potent inhibitor of protein phosphatases 1 and 2A, 21 we studied whether this inhibitor also induced apoptotic cell death.
encoding Bcl-2 (K562-Bcl-2) or Bcl-X L (K562-Bcl-X L ). 17,18 Following exposure to 15 nM OA, K562-Neo cells showed mor-K562 cells incubated in the presence of 5 nM calyculin A for 1 and 2 days, showed a pattern of internucleosomal DNA phological changes, characteristic of apoptosis (Figure 4a ). By contrast, K562-Bcl-X L and K562-Bcl-2 cells were not affected fragmentation characteristic of apoptosis (Figure 3b) , and this loss of cell viability was accompanied by downregulation of by the same concentration of OA. As shown in Figure 4b , internucleosomal cleavage of genomic DNA was only Bcl-2 and Bcl-X L mRNA and protein (not shown).
To test the ability of Bcl-2 and Bcl-X L to protect K562 cells observed in K562-Neo cells. Furthermore, after 3 days of treatment with OA, the expression of Bcl-X L in Bcl-X L -transfected from apoptosis induced by OA, we used our previously described K562 cells transfected either with pSFFV-Neo K562 cells was only slightly decreased, most likely due to the loss of endogenous protein, and the expression of Bcl-2 in expression vector alone (K562-Neo) or containing a cDNA
Figure 2
Western blot analysis of Bcl-X L , Bcl-2, and Bax in K562, KU812, and HL-60 cells treated with OA. At the indicated times, lysates (2 × 10 6 cells/lane) were loaded onto a 12% polyacrylamide gel. After electrophoresis, proteins were transferred to nitrocellulose and analyzed for Bcl-X L , Bcl-2, and Bax with rabbit polyclonal antibodies followed by alkaline phosphatase-conjugated goat anti-rabbit IgG. Equal loading of the lanes was verified by staining of the upper part of the gel with Coomassie brilliant blue. Bcl-2-transfected K562 cells remained unaffected (Figure 4c ).
The expression of Bax, a functional regulator of Bcl-2 was also analyzed. We have observed in a growth factor-dependent Thus, overexpression of either Bcl-2 or Bcl-X L in K562 cells conferred resistance to apoptotic cell death induced by OA. erythroleukemia cell line that the apoptotic cell death induced by different signals was accompanied by downregulation of the Bcl-X L mRNA levels, whereas the mRNA levels of Bax remained unchanged. 25 Recent data also showed that Discussion although the Bcl-X L level in B9 myeloma cells was downregulated upon IL-6 deprivation, Bax expression remained OA has been found to induce apoptotic cell death in myeloid leukemia cell lines (K562, HL-60 and U937). 11, 12 Recently, unchanged. 26 Interestingly, the expression of Bax mRNA and protein in the myeloid leukemia cell lines was downregulated we have described that K562 cells do not produce endogenous Bcl-2 but express Bcl-X L , a Bcl-2-related protein that following OA treatment. Since it has been suggested that the ratio of death antagonists (Bcl-2, Bcl-X L , Mcl-1, A1) to agonists inhibits apoptosis upon growth factor withdrawal. 16, 17 In contrast, HL-60 cells express Bcl-2 but very low levels of Bcl-(Bax, Bad, Bcl-X S , Bid) determines whether a cell will respond to an apoptotic signal, 27 we argue that an apoptosis agonist X L . 17, 18 In this report, we have examined whether the incubation of myeloid cell lines (HL-60, K562 and KU812) with other than Bax might be involved in the apoptotic cell death induced by OA. We have also shown that OA did not provoke nanomolar concentrations of OA induced a loss of expression of survival genes (Bcl-2 and/or Bcl-X L ) and whether the constia nonspecific loss of gene expression since the expression of other genes was either maintained (⑀-globin) or upregulated tutive expression of these genes was able to prevent apoptosis of myeloid cells exposed to OA. We found that treatment of (c-fos, vimentin) in K562 cells treated with OA. Furthermore, it has been described that 20-40 nM OA inhibits reticulocyte all three cell lines with OA led to progressive loss of cell viability by activation of an apoptotic process, as previously lysate protein synthesis by increasing the net phosphorylation of elongation factor 2. 28 Our results show that the expression described for HL-60 and K562 cells.
12 Moreover, the loss of cell viability was associated with diminished expression of of exogenous induce inhibition of protein synthesis.
